Bradley Mark J. Johnson & Johnson Transaction History

Bradley Mark J.

$99.3 Million
Q2 2023

A detailed history of Bradley Mark J. transactions in Johnson & Johnson stock. As of the latest transaction made, Bradley Mark J. holds 22,797 shares of JNJ stock, worth $3.31 Million. This represents 3.8% of its overall portfolio holdings.

Number of Shares

22,797

Previous 33,018 30.96%

Holding current value

$3.31 Million

Previous $5.12 Million 26.27%

% of portfolio

3.8%

Previous 3.71%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$154.35 - $166.11 $1.58 Million - $1.7 Million	-10,221 Reduced 30.96%	22,797 $3.77 Million
Q1 2023 Jun 09, 2023	BUY	$151.05 - $180.26 $10,573 - $12,618	70 Added 0.21%	33,018 $5.12 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $581,542 - $694,001	3,850 Added 13.23%	32,948 $5.11 Million
Q4 2022 Feb 15, 2023	SELL	$160.2 - $179.79 $28,034 - $31,463	-175 Reduced 0.6%	29,098 $5.14 Million
Q3 2022 Nov 15, 2022	BUY	$161.33 - $179.52 $13,713 - $15,259	85 Added 0.29%	29,273 $4.78 Million
Q2 2022 Jul 15, 2022	SELL	$168.19 - $186.01 $37,001 - $40,922	-220 Reduced 0.75%	29,188 $5.18 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $90,139 - $102,366	-570 Reduced 1.9%	29,408 $5.21 Million
Q4 2021 Mar 07, 2022	SELL	$155.93 - $173.01 $114,452 - $126,989	-734 Reduced 2.39%	29,978 $5.13 Million
Q3 2021 Nov 08, 2021	SELL	$161.5 - $179.47 $67,830 - $75,377	-420 Reduced 1.35%	30,712 $4.96 Million
Q2 2021 Jul 22, 2021	SELL	$159.48 - $171.07 $353,886 - $379,604	-2,219 Reduced 6.65%	31,132 $5.13 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $150,773 - $167,922	-985 Reduced 2.87%	33,351 $5.48 Million
Q4 2020 Feb 18, 2021	BUY	$137.11 - $157.38 $4.71 Million - $5.4 Million	34,336 New	34,336 $5.4 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Mark J., based on Form 13F filings with the SEC.

News

Stay updated on Bradley Mark J. with notifications on news.

Account